Legal Representation
Attorney
Glenn A. Gundersen
USPTO Deadlines
Next Deadline
825 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-10-12)
Due Date
October 12, 2027
Grace Period Ends
April 12, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
41 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 12, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Sep 8, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Sep 7, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Aug 20, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 19, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Aug 19, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Aug 11, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 11, 2021 | IUAF | S | USE AMENDMENT FILED |
| Aug 10, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Aug 10, 2021 | INCE | O | ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST |
| Aug 4, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Aug 4, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 4, 2021 | EXT4 | S | SOU EXTENSION 4 FILED |
| Jul 22, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 20, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jul 20, 2021 | EXT3 | S | SOU EXTENSION 3 FILED |
| Jul 20, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Jan 23, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 21, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 21, 2021 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jan 21, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jul 22, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 20, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jul 20, 2020 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jul 20, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jan 21, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Nov 26, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Nov 26, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Nov 6, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 23, 2019 | ALIE | A | ASSIGNED TO LIE |
| Oct 16, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 11, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Oct 11, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Oct 11, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Oct 11, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Oct 10, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Oct 10, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Oct 10, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Oct 2, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 22, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 19, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancers, rare diseases, primary immune disorders and other diseases
First Use Anywhere:
Jun 23, 2020
First Use in Commerce:
Jun 23, 2020
Class 042
Research and development in the pharmaceutical field; scientific research; scientific investigations for medical purposes
First Use Anywhere:
Jun 11, 2019
First Use in Commerce:
Jun 11, 2019
Additional Information
Pseudo Mark
XFOUR PHARMACEUTICALS
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"